5Suppliers
0Customers
1Debt Items
0Related Chains

XBiotech Inc. Suppliers

TickerNameConfidenceEvidence
THIRD-PARTY-SERVICE-PROVIDERS THIRD-PARTY-SERVICE-PROVIDERS 92% Clinical Trial Accruals Expense accruals related to clinical trials are based on actual services received and efforts expended pursuant to contracts with third party service providers which conduct a…
WHITLEY-PENN WHITLEY-PENN 92% In connection with the audit of the 2025 and 2024 financial statements, the Company entered into an engagement agreement with Whitley Penn which sets forth the terms by which Whitley Penn will perfor…
VENDORS VENDORS 90% The Company accrues costs based on the actual services rendered in the period over which services were performed and the level of effort expended in each period based upon patient enrollment, clinica…
LONZA-SALES-AG LONZA-SALES-AG 75% Licensing Agreement dated January 16, 2015 between XBiotech USA, Inc. and Lonza Sales AG
SOUTH-TEXAS-BLOOD-TISSUE-CENTER SOUTH-TEXAS-BLOOD-TISSUE-CENTER 75% Research and Collaboration Agreement dated December 15, 2014 by and between XBiotech USA, Inc. and the South Texas Blood & Tissue Center

XBiotech Inc. Customers

No clients on recordNo downstream customers found in our database for XBiotech Inc..

XBiotech Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
XBIT-DEBT-13642 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-09-30.

XBiotech Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for XBiotech Inc..

XBiotech Inc. Ownership

HolderNameConfidenceEvidence
XBIT-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 42 tracked holders.

XBiotech Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.